Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp270 | Thyroid non cancer - Benign Thyroid disease/ treatment | ECE2018

Body composition changes during treatment of severe thyroid disorders. Is it always fat?

Zybek-Kocik Ariadna , Sawicka-Gutaj Nadia , Szczepanek-Parulska Ewelina , Krauze Tomasz , Guzik Przemyslaw , Ruchala Marek

Severe thyroid disorder are associated with important metabolic changes. After restoration of euthyroidism, as a result of proper treatment, usually body metabolism also normalizes. Up to date, there are conflicting reports about the changes in body composition of patients during treatment of severe hyperthyroidism and hypothyroidism. The aim of this study was to evaluate the body composition and glucose level changes in subjects affected by Graves disease and autoimmune thyro...

ea0081p710 | Reproductive and Developmental Endocrinology | ECE2022

Age- and body mass index-adjusted association between insulin sensitivity and risk factors for cardiovascular disease in polycystic ovary syndrome

Kałużna Małgorzata , Krauze Tomasz , Kompf Pola , Ziemnicka Katarzyna , Andrzej Wykretowicz , Ruchala Marek , Guzik Przemyslaw

Introduction: Impaired insulin sensitivity accompanies polycystic ovary syndrome (PCOS). Women with PCOS are usually at risk of premature cardiovascular disease, which increases with age and body weight. We studied the link between insulin sensitivity measured by the Matsuda Insulin Sensitivity Index (MISI) adjusted to body mass index (BMI) and age in otherwise healthy PCOS women.Methods: 250 adult women with PCOS of reproductive age (18-43 years old) un...

ea0081p199 | Reproductive and Developmental Endocrinology | ECE2022

Is N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) disturbed in polycystic ovary syndrome?

Kałużna Małgorzata , Kompf Pola , Ziemnicka Katarzyna , Tomasz Krauze , Wachowiak-Ochmańska Katarzyna , Wykre¸towicz Andrzej , Guzik Przemyslaw , Ruchala Marek

Introduction: Polycystic ovary syndrome (PCOS) patients present with or without biochemical hyperandrogenism (HAPCOS or non-HAPCOS, respectively). Although cardiometabolic and hormonal abnormalities have been reported in women with PCOS, particularly those with hypertension, direct comparisons between normotensive (blood pressure (BP) <140/90 mmHg) patients with HAPCOS and non-HAPCOS are scarce. Data on N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) in PCO...